Nombre total de rapports de communication : 2
Rapports mensuels de communications au cours des 6 derniers mois : 0
On December 8th, 2005, GlaxoSmithKline purchased all the issued and outstanding shares of ID Biomedical Corporation. The Corporation has nonetheless survived the closing of the above noted transaction and now carries on business as IB Biomedical Corporation cob as GlaxoSmithKline Biologicals North America. The Corporation is an integrated biotechnology company dedicated to the development of innovative vaccine products. It operates in research, development, manufacturing, sales and marketing from its facilities in Canada and in the United States.
John Picken, President
Adresse :
525 Cartier Blvd. West
Laval, QC H7V 3S8
Canada
Numéro de téléphone :
450-978-6301
Numéro de fax :
450-978-7956
ID BIOMEDICAL CORPORATION ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement